Picture of Damora Therapeutics logo

DMRA — Damora Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Galecto Resumes Recruitment In Phase 2B Global GALACTIC-1 Trial Of GB0139

July 13 (Reuters) - Galecto Inc  GLTO.O :
    * GALECTO RESUMES RECRUITMENT IN PHASE 2B GLOBAL GALACTIC-1
TRIAL
OF GB0139 FOR IDIOPATHIC PULMONARY FIBROSIS

Source text for Eikon:  ID:nGNX78bJDX 
Further company coverage:  GLTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Damora Therapeutics

See all news